Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

MedCAD AccuShape Titanium Patient-Specific Cranial Implant

K-Number: K220357 · 2022-08-26

ApplicantMedcad
Decision Date2022-08-26
Product CodeGXN
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

MedCAD AccuShape Titanium Patient-Specific Cranial Implant is a medical device manufactured by Medcad. It received FDA 510(k) clearance on 2022-08-26 under approval number K220357. The device is classified under product code GXN. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MedCAD AccuShape Titanium Patient-Specific Cranial Implant?

MedCAD AccuShape Titanium Patient-Specific Cranial Implant is a medical device that received FDA 510(k) clearance on 2022-08-26. It is manufactured by Medcad. The 510(k) number is K220357.

When was MedCAD AccuShape Titanium Patient-Specific Cranial Implant approved by the FDA?

MedCAD AccuShape Titanium Patient-Specific Cranial Implant received FDA 510(k) clearance on 2022-08-26, under approval number K220357.

What company makes MedCAD AccuShape Titanium Patient-Specific Cranial Implant?

MedCAD AccuShape Titanium Patient-Specific Cranial Implant is manufactured by Medcad.

What is the FDA product code for MedCAD AccuShape Titanium Patient-Specific Cranial Implant?

The FDA product code for MedCAD AccuShape Titanium Patient-Specific Cranial Implant is GXN.

Related Clinical Trials

Related PubMed Literature

Other Devices by Medcad

View all 9 devices →

Related Devices (Code: GXN)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.